Gerard Sheehan

Director, Global Medical Affairs at Sarepta Therapeutics

Gerard Sheehan, PhD has a diverse work experience spanning various industries and roles. Gerard currently holds the position of Director, Global Medical Affairs at Sarepta Therapeutics, a biotechnology company. Prior to that, they worked as a Senior Medical Science Liaison Manager at Inflammatix, Inc. and as a Medical Science Liaison at Adaptive Biotechnologies Corp.

Earlier in their career, Dr. Sheehan worked at Eli Lilly and Company as part of the Global Scientific Communications team, focusing on immunology. Gerard also served as a Medical Sciences Recorder at the British Science Association and as the Eukaryotic Division Representative at the Microbiology Society.

Before transitioning into the field of medical science liaison, Dr. Sheehan gained research experience at various institutions. Gerard worked as a Post Doctoral Research Fellow at the University of Birmingham, focusing on unknown cellular interactions. Additionally, they served as a Research Manager at Qualflow Systems and conducted research as a Research Scientist at Queen's University Belfast and Maynooth University.

At Maynooth University, Dr. Sheehan contributed to research projects related to ocular rosacea and the geographical and seasonal variation of Nosomosis in Apis mellifera populations. These projects involved cell culture, inflammatory response measurement, and data analysis.

Overall, Dr. Gerard Sheehan's work experience showcases their expertise in medical affairs, scientific communications, research, and project management.

Dr. Gerard Sheehan has a diverse education history. In 2014, they obtained their Doctor of Philosophy (Ph.D.) in Microbiology and Immunology from Maynooth University. Gerard then pursued a Professional Certificate in Teaching & Learning from the same university in 2016. Prior to that, in 2011, they completed their undergraduate studies at Maynooth University, earning a Bachelor of Science (BSc) in Biological & Biomedical Sciences with a focus on Biology. In 2024, Dr. Sheehan attended The London School of Economics and Political Science (LSE) to obtain a Postgraduate Certificate in Health Economics and Policy. Additionally, they hold a certification in Good Clinical Practice (GCP) from the NIHR (National Institute for Health and Care Research), obtained in 2022.

Links

Previous companies

Adaptive Biotechnologies logo
University of Birmingham logo
Inflammatix logo

Timeline

  • Director, Global Medical Affairs

    April, 2023 - present